GlaxoSmithKline S.A.E (BIOC) Share Price
GlaxoSmithKline S.A.E (BIOC) is listed on the Egyptian Exchange and trades in EGP (E£). The sector is not yet verified in the current source set. Current market capitalisation stands at E£5.98B. Data on Mansa Markets refreshes every 30 minutes during EGX trading hours (10:00–14:30 Cairo).
| Ex-Dividend Date | Cash Amount | Record Date | Pay Date |
|---|---|---|---|
| 12 Jan 2026 | 1 EGP | 13 Jan 2026 | 14 Jan 2026 |
| 18 Jul 2024 | 0.75 EGP | 17 Jul 2024 | 22 Jul 2024 |
| 4 Jul 2023 | 0.75 EGP | 26 Jun 2023 | 6 Jul 2023 |
| 4 Jan 2023 | 3 EGP | 3 Jan 2023 | 8 Jan 2023 |
| 20 Sept 2022 | 0.75 EGP | 19 Sept 2022 | 22 Sept 2022 |
| 5 Jul 2021 | 0.5 EGP | 4 Jul 2021 | 7 Jul 2021 |
GlaxoSmithKline S.A.E (BIOC) — Frequently Asked Questions
What is the GlaxoSmithKline S.A.E (BIOC) share price today?
GlaxoSmithKline S.A.E (BIOC) trades at E£71.63 on the Egyptian Exchange, up 3.56% on the day, as of 15 June 2026. Prices are quoted in EGP.
What is GlaxoSmithKline S.A.E's market capitalisation?
GlaxoSmithKline S.A.E has a market capitalisation of E£5.98B (EGP) on the EGX, as of 15 June 2026.
Does GlaxoSmithKline S.A.E (BIOC) pay dividends?
Yes. The most recent GlaxoSmithKline S.A.E dividend on record is EGP 1 with an ex-dividend date of 12 January 2026 and payment on 14 January 2026.
How can I buy BIOC shares in Egypt?
BIOC shares trade on the Egyptian Exchange and can be bought through a licensed Egypt stockbroker. Mansa Markets maintains a directory of Egypt stockbrokers to compare options.